Description
Telgard-M 25 Tablet, manufactured by Cipla Ltd., is a combination antihypertensive medicine designed for the treatment of high blood pressure (hypertension) and related cardiovascular risks. It brings together two medicines that work in complementary ways:
-
Telmisartan (40mg): An angiotensin II receptor blocker (ARB) that relaxes and widens blood vessels, thereby lowering blood pressure and improving blood circulation.
-
Metoprolol Succinate (25mg): A beta-blocker that reduces the heart rate and cardiac workload, helping prevent heart-related complications.
Together, they help achieve better blood pressure control than when either drug is used alone, while also lowering the risk of heart attack, stroke, and heart failure.
Medical Uses
-
Treatment of essential hypertension
-
Reduces the risk of stroke, heart attack, and heart failure
-
Provides protection for patients with left ventricular dysfunction or cardiac conditions
-
Often prescribed for patients who require both ARB and beta-blocker therapy
Benefits
-
Dual mechanism of action: relaxes blood vessels and lowers heart rate
-
More effective blood pressure control in patients uncontrolled on monotherapy
-
Reduces strain on the heart, helping in long-term cardiovascular protection
-
Once-daily dosing for convenience and compliance
Possible Side Effects
-
Dizziness, tiredness, or headache
-
Slow heartbeat (bradycardia)
-
Low blood pressure (hypotension)
-
Cold hands/feet, mild swelling
-
Rare: Shortness of breath, worsening asthma, or abnormal heart rhythm
Warnings & Precautions
-
Not safe during pregnancy and breastfeeding
-
Should be used cautiously in patients with asthma, COPD, or bradycardia
-
Avoid sudden discontinuation, as it may cause rebound hypertension or angina
-
Regular monitoring of blood pressure, heart rate, and kidney function is recommended
-
Patients should avoid excessive alcohol, which can worsen dizziness or low BP
Leave a Reply